Workflow
Biopharmaceutical analysis
icon
Search documents
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
Prnewswire· 2025-05-21 12:00
Core Insights - Waters Corporation has acquired Halo Labs, a company specializing in imaging technologies for detecting and analyzing particles in therapeutic products, enhancing Waters' capabilities in large molecule development and quality assurance [1][2][3] Company Overview - Waters Corporation is a global leader in analytical instruments and technologies, serving various sectors including life sciences, materials, food, and environmental sciences for over 65 years [5] - Halo Labs is a venture-backed company that provides high throughput biopharmaceutical formulation and quality control tools, focusing on particle analysis [4] Technology and Innovation - The Aura platform from Halo Labs offers full spectrum particle analysis, complementing Waters' existing light scattering detection solutions, particularly beneficial for CAR T-cell therapies [2][3] - The acquisition allows Waters to integrate Halo's technology into its product offerings, providing added value to customers and supporting growth in analytical and bioprocessing testing [2][3] Strategic Impact - The acquisition is expected to have a negligible impact on Waters' income statement over the next 12 months, indicating a strategic long-term investment rather than an immediate financial burden [3]